deltatrials
Unknown NA NCT00997412

Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis

Randomized, Double-blind, Double-dummy Trial of Mycophenolic Acid Versus Azathioprine in the Treatment of Corticosteroid-refractory Myasthenia Gravis

Sponsor: Qualitix Clinical Research Co., Ltd.

Conditions Myasthenia Gravis
Interventions AZA Mycophenolic acid
Updated 4 times since 2017 Last updated: Oct 16, 2009 Started: May 31, 2009 Primary completion: May 31, 2011 Completion: May 31, 2011

Listed as NCT00997412, this NA trial focuses on Myasthenia Gravis and remains ongoing. Sponsored by Qualitix Clinical Research Co., Ltd., it has been updated 4 times since 2009, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Change History

4 versions recorded

  1. Sep 2024 — Present [monthly]

    Unknown NA

  2. Jul 2024 — Sep 2024 [monthly]

    Unknown NA

    Status: Unknown Status → Unknown

  3. Jan 2021 — Jul 2024 [monthly]

    Unknown Status NA

  4. Jan 2017 — Jan 2021 [monthly]

    Unknown Status NA

    First recorded

May 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Qualitix Clinical Research Co., Ltd.
Data source: Qualitix Clinical Research Co., Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

No location information available.